The Multicenter Acute Stroke Trial (MAST)—Thrombolysis Study: Study Design and Progress Report
Acute ischemic stroke is the third major cause of death in developed countries, and a major cause of disability. Despite a very poor prognosis, no treatment has demonstrated an efficacy in lowering the mortality and disability resulting from stroke events. Thrombolysis has been proven to reduce mortality in myocardial infarction [1–3], and it has been shown able to induce recanalization when administered to acute stroke patients. A recent meta-analysis of small-sized studies suggests that thrombolysis could offer some benefit to stroke patients by reducing the mortality and severe invalidity by 63%; these results need to be confirmed in adequately designed and sized studies . The Multicenter Acute Stroke Trial (MAST) is an ongoing stroke trial comparing streptokinase and placebo. Its rationale has been developed elsewhere .
KeywordsAcute Ischemic Stroke Steering Committee Acute Stroke Patient Data Monitoring Committee Drug Supply
Unable to display preview. Download preview PDF.
- 1.ISIS-2 Collaborative Group (1988) Randomised trial of intraveneous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349–360Google Scholar
- 2.Gruppo Italiano per lo Studio della Streptochinasi nell’Infarcto miocardico (GISSI) (1990) GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 336: 65–71Google Scholar
- 3.ISIS-3 (Third International Study of Infarct Survival) Collaborative Group (1992) ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 339: 753–770CrossRefGoogle Scholar
- 5.Hommel M, Cornu C, on behalf of the MAST Group (1993) Rationale for testing thrombolysis in acute is haemic stroke. Clin Trials Meta-Anal 28: 345–356Google Scholar
- 6.The MAST Group (1993) Protocol for the Multicenter Acute Stroke Trial—thrombolysis study. Clin Trials Meta-Anal 28: 329–344Google Scholar
- 10.Orgogozo JM, Dartigues JF (1986) Clinical trials in brain infarction: the question of assessment criteria. In: Battistini N, Fiorani P, Courbier R, Plum F, Fieschi C (eds) Acute brain ischemia: medical and surgical therapy. Raven, New York, pp 201–208Google Scholar
- 11.Candelise L, Pinardi G, Aritzu E (1990) Stroke disability assessed by telephone interview: reliability and reproducibility. J Neurol 237: 143Google Scholar
- 12.Whitehead J (1983) The design and analysis of sequential clinical trials. Chichester: Ellis HorwoodGoogle Scholar
- 14.Boissel JP, Bossard N (1992) Registry of multicenter clinical trials. Twelfth and thirteenth report—1990–1991. Thromb Haemostasis 68: 752–778Google Scholar